An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A news report says that more than 100 deaths have been recorded in people who used Mounjaro or Wegovy. The number comes from reports collected after those drugs were taken. The story does not by itself prove the drugs caused the deaths; it’s a tally of reports, not a verdict. Mounjaro and Wegovy are brand-name medicines that act like hormones your body makes. Wegovy contains semaglutide, and Mounjaro contains tirzepatide. These drugs mimic signals from the gut that tell your brain you’re full, slow stomach emptying, and change how the body handles sugar. Doctors prescribe them mainly for weight loss or for treating diabetes. They are powerful medicines, not simple supplements. The report summarizes adverse-event reports — basically, instances where someone who took one of these drugs later died and that death was reported to health databases or the media. The key point is this is a count of reports, not a controlled scientific study. It doesn’t necessarily show the drugs caused the deaths, how large the risk is compared with people who didn’t take them, or whether other illnesses or factors were responsible. The article likely doesn’t provide full medical records, detailed causes of death, or statistical analysis that would be needed to draw strong conclusions. This matters because these drugs are being used by many people, sometimes outside strict medical guidance. If there are real safety signals, regulators and doctors need to know so they can update guidance, screen patients carefully, or adjust monitoring. For a regular person considering these medicines, it’s a reminder to discuss risks and benefits with a clinician, especially if you have other health problems, take other medications, or are getting these drugs through nonmedical channels. There are important caveats. Adverse-event reports are useful for spotting possible problems, but they are incomplete and can’t prove cause and effect. Some deaths may be unrelated to the drug; some may reflect underlying disease, age, drug interactions, or reporting bias (more attention leads to more reports). These medicines have known side effects — nausea, digestive issues, and rare but serious risks identified in trials — and they should be used under medical supervision. Regulatory agencies review such reports and may investigate further; until that process concludes, the raw count alone is not a definitive measure of safety. Bottom line: More than 100 deaths have been reported after use of Mounjaro or Wegovy, but reports are not the same as proof, and more investigation is needed to understand whether and how the drugs were involved.
Source: thetimes.com